Which hedge funds own MIRM? MIRUM PHARMACEUTICALS INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
6 of the hedge funds tracked by WhaleCreep disclosed a position in MIRM (MIRUM PHARMACEUTICALS INC) in their Q2 2026 13F filings, worth $172.5m in total. The largest holder by portfolio weight is RA Capital Management at 0.3% of its book. 3 exited: Farallon Capital Management, Marshall Wace, Point72 Asset Management LP.
6tracked managers holding
0opened this quarter
3exited this quarter
Which hedge funds hold MIRM? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| RA Capital Management | Q2 2026 | 0.3% | $37.3m | 318,554 | 0% | held |
| Woodline Partners | Q2 2026 | 0.2% | $66.5m | 567,894 | 0% | held |
| Renaissance Technologies LLC | Q2 2026 | 0.1% | $51.8m | 442,185 | -24% | reduced |
| Polen Capital Management | Q2 2026 | 0.0% | $2.4m | 20,899 | 2% | added |
| Millennium Management | Q2 2026 | 0.0% | $11.3m | 96,213 | -74% | reduced |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $3.3m | 27,879 | -83% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Farallon Capital Management | 0.0% | $277.1k |
| Marshall Wace | 0.0% | $429.6k |
| Point72 Asset Management LP | 0.6% | $28.2m |
How has hedge fund ownership of MIRM changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 6 | $172.5m |
| Q1 2026 | 10 | $345.2m |
| Q4 2025 | 6 | $120.7m |
| Q3 2025 | 6 | $163.1m |
| Q2 2025 | 4 | $79.7m |
| Q1 2025 | 4 | $64.9m |
| Q4 2024 | 5 | $78.2m |
| Q3 2024 | 4 | $71.7m |
| Q2 2024 | 3 | $54.1m |
| Q1 2024 | 2 | $34.6m |
| Q4 2023 | 3 | $42.9m |
| Q3 2023 | 4 | $53.2m |
| Q2 2023 | 4 | $24.6m |
| Q1 2023 | 3 | $26.3m |
| Q4 2022 | 3 | $15.5m |
| Q3 2022 | 1 | $7.5m |
Counts every tracked manager that disclosed MIRM in that quarter's filing, including managers that have since stopped filing.